Latest News and Press Releases
Want to stay updated on the latest news?
-
Intern viden ALK (ALKB:DC / OMX: ALK B) har i dag annonceret, at Det Europæiske Lægemiddelagenturs komite for godkendelse af medicin til mennesker (Committee for Medicinal Products for Human Use,...
-
Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Committee for Medicinal Products for Human Use (‘CHMP’) of the European Medicines Agency has adopted a positive opinion...
-
ALK (ALKB:DC / OMX: ALK B) today announced that the company’s president & CEO, Peter Halling, is scheduled to give a company presentation at the 44th Annual J.P. Morgan Healthcare Conference in...
-
Finanskalender 2026 for ALK (ALKB:DC / OMX: ALK B): 23. januar 2026: Stilleperiode20. februar 2026: Offentliggørelse af årsrapport 202516. marts 2026 kl. 16.00: ...
-
2026 financial calendar for ALK (ALKB:DC / OMX: ALK B): 23 January 2026: Silent period 20 February 2026: Annual report...
-
I henhold til § 30 i Lov om kapitalmarkeder skal ALK (ALKB:DC / OMX: ALK B) hermed oplyse, at Arbejdsmarkedets Tillægspension (“ATP”) har meddelt, at ATP har reduceret sin ejerandel i ALK til under 5%...
-
Pursuant to Section 30 of the Danish Capital Markets Act, ALK (ALKB:DC / OMX: ALK B) hereby announces that Arbejdsmarkedets Tillægspension (“ATP”) (The Danish Supplementary Labour Market Pension) has...
-
ALK (ALKB:DC / OMX: ALK B) har i dag annonceret udnævnelsen af Edward Jordan til ny Executive Vice President (EVP) og direktør for de kommercielle aktiviteter i Nordamerika med virkning fra 5. januar...
-
ALK (ALKB:DC / OMX: ALK B) today announced the appointment of Edward Jordan as new Executive Vice President (EVP) and head of Commercial Operations in North America as per 5 January 2026. Edward...
-
Bemærk venligst, at rapporten udelukkende forefindes på engelsk. ALK delivers 18% global organic revenue growth with operating profit up 41% in Q3 Results were better than expected, driven by a...